Aptose Biosciences Inc. (APTO)
NASDAQ: APTO
· Real-Time Price · USD
1.71
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Aptose Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -21.33M | -25.43M | -35.8M | -40.29M | -47.17M | -51.21M | -49.25M | -47.58M | -44.02M | -41.82M | -56.15M | -57.7M | -60.61M | -65.35M | -55.74M | -57.66M | -59.94M |
Depreciation & Amortization | 394K | 403.51K | 416.51K | 431.51K | 443.51K | 466K | 456K | 486K | 513K | 528K | 591K | 605K | 616K | 622K | 613K | 611K | 611K |
Stock-Based Compensation | 577K | 1.06M | 1.41M | 2.03M | 2.59M | 3.65M | 4.1M | 4.56M | 4.57M | 5.21M | 6.66M | 7.43M | 8.82M | 12.95M | 15.07M | 18.14M | 23.68M |
Other Working Capital | -5.64M | -6.22M | -2.38M | -3.23M | 2.07M | 2.67M | 919K | 1.5M | 1.08M | -345.43K | 893.57K | 1.97M | 1.83M | 1.84M | 2.72M | 564.44K | 170.44K |
Other Non-Cash Items | -980K | -999.26K | -89.43K | -126.43K | -142.43K | -150.17K | -613K | -502K | -497.57K | -515.57K | 7.5M | 7.42M | 7.23M | 7.11M | -368.93K | -492.44K | -388.44K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -5.67M | -11.01M | -3.36M | 382.84K | -1.02M | 2.39M | 1.31M | 2.61M | 5.46M | 4.28M | 1.68M | 1.44M | 1.37M | 1.37M | 2.82M | 1.58M | -124.56K |
Operating Cash Flow | -27.01M | -35.98M | -37.42M | -37.58M | -45.31M | -44.84M | -43.99M | -40.44M | -33.98M | -32.32M | -39.72M | -40.8M | -42.57M | -43.3M | -37.61M | -37.82M | -36.16M |
Capital Expenditures | -6K | -5K | 939.03 | 939.03 | -28.06K | -29.06K | -29K | -29K | -24K | -24K | -38K | -219K | -195K | -212K | -224K | -43K | -80K |
Cash Acquisitions | n/a | 995.53 | 995.53 | 995.53 | 995.53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -1.93M | -4.89M | -4.89M | -4.89M | -2.96M | n/a | -19.81M | -19.82M | -19.82M | -39.81M | -20M | -24.39M | -24.39M |
Sales Maturities Of Investments | n/a | n/a | 1.93M | 14.88M | 14.88M | 14.88M | 25.45M | 12.49M | 22.59M | 30.09M | 17.59M | 17.59M | 12.5M | 5M | 5M | 5M | 1.52M |
Other Investing Acitivies | 2.01M | 16K | 79.41K | 79.41K | -1.93M | 63.41K | 5.08M | n/a | n/a | n/a | -5.26M | -184.53K | -184.53K | -184.53K | 27.98M | 27.98M | 27.98M |
Investing Cash Flow | 2M | 11K | 2.01M | 14.96M | 10.99M | 10.02M | 25.61M | 7.58M | 19.6M | 30.07M | -7.52M | -2.62M | -7.69M | -35.21M | 12.76M | 8.55M | 5.03M |
Debt Repayment | 10M | 10M | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 27K | 26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 11K | 62.92K | -106.08K | -56.08K | 115.92K | 79K | 70.12K | 12.12K | 17.42K | 16.42K | 45.3K | 45.3K | 130K | 190K | 34K | 83K | 44K |
Financial Cash Flow | 22.4M | 33.41M | 27.46M | 22.36M | 18.71M | 6.91M | 6.11M | 1.23M | 151K | 116K | 131K | 110K | 166K | 226K | 202K | 58.48M | 58.45M |
Net Cash Flow | -2.6M | -2.54M | -7.76M | -70K | -15.42M | -27.72M | -12.27M | -31.63M | -14.23M | -2.14M | -47.1M | -43.31M | -50.09M | -78.28M | -24.63M | 29.23M | 27.33M |
Free Cash Flow | -27.01M | -35.93M | -37.12M | -37.28M | -45.04M | -44.63M | -44.02M | -40.46M | -34M | -32.35M | -39.75M | -41.01M | -42.77M | -43.52M | -37.84M | -37.87M | -36.24M |